Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction

Medical Science Monitor

Volumn 9, Issue 12, 2003, Pages

  Nakayama, Tomohiro ^a,b   Soma, Masayoshi ^a   Saito, Satoshi ^a   Honye, Junko ^a   Sato, Mikano ^a   Aoi, Noriko ^a   Kosuge, Kotoko ^a   Haketa, Akira ^a   Kanmatsuse, Katsuo ^a   Kokubun, Shinichiro ^a  

^a Nihon Medical University   (Japan)

^b Advanced Medical Research Center   (Japan)

Author keywords

Association study; Missense mutation; Myocardial infarction; Natriuretic peptide receptor gene

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; ISOLEUCINE; METHIONINE; NUCLEOTIDE; PRIMER DNA;

ADULT; AGED; ALLELE; ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; EXON; FEMALE; GENETIC MARKER; GENOTYPE; HEART INFARCTION; HUMAN; JAPAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

AGED; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EXONS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GUANYLATE CYCLASE; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIAL INFARCTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RISK FACTORS;

EID: 10744233202     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Marenberg ME, Risch N, Berkman LF et al: Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med, 1994; 330: 1041-6
2. Nota JJ, Lortscher RH, Spangler RD et al: Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation, 1980; 61: 503-8
3. Cambien F, Poirier O, Lecerf L et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 1992; 359: 641-4
4. van Bockxmeer FM, Mamotte CDS: Apolipoprotein 4 homozygosity in young men with coronary heart disease. Lancet, 1992; 340: 879-80
5. Weiss EJ, Bray PF, Tayback M et al: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med, 1996; 334: 1090-4
6. Wu KK: Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med, 1996; 239: 17-34.
7. Patrono C: Prevention of myocardial infarction and stroke by aspirin: different mechanisms? Different dosage? Thromb Res, 1998; 92(suppl 1): S7-12.
8. Trip MD, Cats VM, van Capelle FJ, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med, 1990; 322: 1549-54
9. Laragh JH: Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med, 1985; 313: 1330-1340
10. Lowe DG, Chang M-S, Hellmiss R et al: Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J, 1989; 8: 1377-1384
11. Chang M-S, Lowe DG, Lewis M et al: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature, 1989; 341: 68-72
12. Fuller F, Porter JG, Arfsten AE et al: Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem, 1988; 263: 9395-9401
13. Yuen PS, Garbers DL: Guanylyl cyclase-linked receptors. Annu Rev Neurosci, 1992; 15: 193-225
14. Koller KJ, Lowe DG, Bunntt GL et al: Selective activation of the B-natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991; 252: 120-123
15. Needleman P, Adams Sp, Coie BR et al: Atriopeptides as cardiac hormones. Hypertension, 1985; 7: 469-482
16. Maack T, Camargo MJF, Kleinert HD et al: Atrial natriuretic factor: structure and functional properties. Kidney Int, 1985; 27: 607-615
17. Meloche S, McNicoll N, Liu B et al: Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amilloride. Biochemistry, 1988; 27: 8151-8169
18. Schenk DB, Phelps MN, Porter JG et al: Purification and subunit composition of atrial natriuretic peptide receptor. Proc Natl Acad Sci USA, 1987; 84: 1521-1525
19. Bennett BD, Bennett GL, Vitangcol RV et al: Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem, 1991; 266: 23060-23067
20. Loeb AL, Gear ARL: Potenyiatio of platelet aggregation by atrial natriuretic peptide. Life Science, 1988; 43: 731-738
21. Takahashi Y, Nakayama T, Soma M et al: Organization of the human natriuretic peptide receptor A gene. Biochem Biophys Res Commun, 1998; 246: 735-739
22. Nakayama T, Soma M, Takahashi Y et al: Nucleotide sequence of the 5′-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. Am J Hypertens, 1999; 12: 1144-1148
23. Nakayama T, Soma M, Mizutani Y et al: A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res, 2002; 25: 395-401
24. Nakayama T, Soma M, Saito S et al: Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am Heart J, 2002; 143: 797-801
25. Chu A, Morris KG, Kuehl WD et al: Effect of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation, 1989; 80: 1627-35
26. Lai CP, Egashira K, Yashiro H et al. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Circulation, 1993; 87: 144-51
27. Tanaka H, Yasue H, Yoshimura M et al. Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic in patients with variant angina. Am J Cardiol, 1993; 72: 128-133
28. Okumura K, Yasue H, Fujii H et al: Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol, 1995; 25: 342-348
29. Zellner C, Protter AA, Ko E et al: Coronary vasodilator effects of BNP: mechanism of action in coronary conductance and resistance arteries. Am J Physiol, 1999; 276(3 Pt 2): H1049-57
30. Schiffrin EL, Deslongchamps M, Thibault G: Platelet binding sites for atrial natriuretic factor in humans. Characterization and effects of sodium intake. Hypertension, 1986; 8 [Supple II]: II-6-II-10
31. Caterina R, Volpe M, Atlas SA et al: Effects of atrial natriuretic factor on human platelet function. Life Sciences, 1985; 37: 1395-1402
32. Lang CC, Lau CS, Belch JJ et al: Effects of atrial natriuretic factor on platelet function in whole blood ex-vivo in man. Eur J Clin Pharmacol, 1990; 39: 589-591
33. Nakayama T, Soma M, Takahashi Y et al: Functional deletion mutation of the 5′-flanking region of the type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res, 2000; 86: 841-845
34. van den Akker F, Zhang X, Miyagi M et al: Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature, 2000; 406: 101-104